NLRP3 and B-cell non-Hodgkin lymphoma: Research highlighted that certain polymorphisms in the genes encoding for NLRP3 inflammasome-related molecules are associated with increased susceptibility to B-cell NHL development and correlate with lymphoma patients’ survival and prognosis.